Canaloplasty business
Ellex Medical Lasers Limited has recently acquired the canaloplasty business of US-based iScience Interventional, Inc which comprises the iTRACK 250 catheter and suture device for the treatment of mildmoderate glaucoma. “This acquisition is very exciting. The new canaloplasty business will allow us to provide our existing customers with a complementary product offering for the treatment of glaucoma. We are also pleased to have existing iTRACK 250 customers join Ellex,” said Ellex CEO, Tom Spurling. www.ellex.com
Latest Articles
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Nutrition and the Eye: A Recipe for Success
A look at the evidence for tasty ways of lowering risks and improving ocular health.
New Award to Encourage Research into Sustainable Practices
Sharing a Vision for the Future
ESCRS leaders update Trieste conference on ESCRS initiatives.
Extending Depth of Satisfaction
The ESCRS Eye Journal Club discuss a new study reviewing the causes and management of dissatisfaction after implantation of an EDOF IOL.
Conventional Versus Laser-Assisted Cataract Surgery
Evidence favours conventional technique in most cases.
AI Scribing and Telephone Management
Automating note-taking and call centres could boost practice efficiency.